Rapid delivery of toxicological material
Drug Target Review
SEPTEMBER 10, 2024
To achieve an aggressive timeline from DNA to investigational new drug (IND) application, drug developers have strengthened collaborations with contract development & manufacturing organisations (CDMOs) to expedite drug development. FDA no longer has to require animal testing for new drugs. References: 1 Wadman M.
64 
Let's personalize your content